BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Martínez-Galán J, Rodriguez I, Caba O. Importance of BRCA mutation for the current treatment of pancreatic cancer beyond maintenance. World J Gastroenterol 2021; 27(39): 6515-6521 [PMID: 34754149 DOI: 10.3748/wjg.v27.i39.6515]
URL: https://www.wjgnet.com/1007-9327/full/v27/i39/6515.htm
Number Citing Articles
1
L Crapé, K Geboes, K Kortbeek, E Naert, A Hoorens, F Berrevoet, N Van Heddeghem, S Ribeiro. Long-term complete remission of two patients with synchronous liver metastasis from pancreatic cancer and underlying BRCA-2 mutationActa Gastro Enterologica Belgica 2024; 87(4): 521 doi: 10.51821/87.4.11787
2
Marie Buchholz, Britta Majchrzak-Stiller, Ilka Peters, Stephan Hahn, Lea Skrzypczyk, Lena Beule, Waldemar Uhl, Chris Braumann, Johanna Strotmann, Philipp Höhn. Maintenance Therapy for Pancreatic Cancer, a New Approach Based on the Synergy between the Novel Agent GP-2250 (Misetionamide) and GemcitabineCancers 2024; 16(14): 2612 doi: 10.3390/cancers16142612